|
|
||||||||
The Journal of Immunology, Vol 134, Issue 3 1851-1858, Copyright © 1985 by American Association of Immunologists
ARTICLES |
PS Changelian, RM Jack, LA Collins and DT Fearon
Phorbol myristate acetate (PMA) has been reported to confer on the C3b receptor (CR1) of neutrophils a capacity for phagocytosis of particles bearing C3b without the involvement of other membrane receptors. In the present study, we employed a monoclonal antibody, YZ-1, that is specific for CR1 to assess the effect of PMA on plasma membrane expression of CR1, total cellular CR1, and internalization of CR1 by neutrophils. PMA had a biphasic effect on the membrane expression of CR1 by purified neutrophils, with 4 ng/ml inducing a 60% increment in receptor expression, and higher concentrations causing up to a 70% decrement. PMA-dependent increases in CR1 expression were not accompanied by corresponding changes in total cellular CR1 and were preempted by treatment of cells with formyl-methionyl-leucyl- phenylalanine (FMLP). PMA-induced decreases in CR1 expression by neutrophils, as measured by binding of indirectly fluoresceinated or radiolabeled YZ-1, or of 125I-labeled dimeric C3b, were maximal with 20 to 30 ng/ml PMA, and occurred within 30 min of incubation at 37 degrees C. The PMA-dependent down-regulation of CR1 by neutrophils was not associated with a comparable decrease in total cellular CR1, and this response was observed to occur also with monocytes but not with peripheral blood lymphocytes. By tagging neutrophil CR1 with 125I-YZ-1 Fab and monitoring accessibility to Protease, intracellular CR1 (inaccessible) was discriminated from receptor on plasma membrane (accessible). Internalization of CR1 occurred within 5 min after addition of PMA to neutrophils, was dose dependent, and involved up to two-thirds of the tagged receptors. Therefore, PMA caused internalization of CR1 by neutrophils in the absence of ligand, indicating that this response was independent of a transmembrane signal generated by a C3b-CR1 interaction.
This article has been cited by other articles:
![]() |
I. Ghiran, A. M. Glodek, G. Weaver, L. B. Klickstein, and A. Nicholson-Weller Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1 Blood, October 15, 2008; 112(8): 3465 - 3473. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Jacobson and J. H. Weis Comparative Functional Evolution of Human and Mouse CR1 and CR2 J. Immunol., September 1, 2008; 181(5): 2953 - 2959. [Full Text] [PDF] |
||||
![]() |
I. Ghiran, S. F. Barbashov, L. B. Klickstein, S. W. Tas, J. C. Jensenius, and A. Nicholson-Weller Complement Receptor 1/Cd35 Is a Receptor for Mannan-Binding Lectin J. Exp. Med., December 18, 2000; 192(12): 1797 - 1808. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xiang, J. R. Rundles, D. R. Hamilton, and J. G. Wilson Quantitative Alleles of CR1: Coding Sequence Analysis and Comparison of Haplotypes in Two Ethnic Groups J. Immunol., November 1, 1999; 163(9): 4939 - 4945. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Tas, L. B. Klickstein, S. F. Barbashov, and A. Nicholson-Weller C1q and C4b Bind Simultaneously to CR1 and Additively Support Erythrocyte Adhesion J. Immunol., November 1, 1999; 163(9): 5056 - 5063. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jost, L. Klickstein, E. Wetzler, A. Kumar, and M. Berger Intracellular Storage and Regulated Plasma Membrane Expression of Human Complement Receptor Type 1 in Rat Basophil Leukemia Cell Transfectants Blood, July 1, 1998; 92(1): 300 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rogers, R. Jack, and S. Furlong Lipid and membrane protein transfer from human neutrophils to schistosomes is mediated by ligand binding J. Cell Sci., January 10, 1993; 106(2): 485 - 491. [Abstract] [PDF] |
||||
![]() |
R. Carter and D. Fearon CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes Science, April 3, 1992; 256(5053): 105 - 107. [Abstract] [PDF] |
||||
![]() |
F. D. Moore Jr, S. H. Socher, and C. Davis Tumor Necrosis Factor and Endotoxin Can Cause Neutrophil Activation Through Separate Pathways Arch Surg, January 1, 1991; 126(1): 70 - 73. [Abstract] [PDF] |
||||
![]() |
D. Reed and F. D. Moore Jr Recombinant Human Tumor Necrosis Factor Increases Granulocyte Cell-Surface Complement Receptor Number Arch Surg, November 1, 1988; 123(11): 1333 - 1336. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |